|Day's Range||26.80 - 27.33|
|52 Week Range||8.58 - 27.63|
|PE Ratio (TTM)||1,285.24|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Emergent's shares inched up post announcement of its deal inked with GlaxoSmithKline to acquire the latter's anthrax monoclonal antibody raxibacumab.
Valeant (VRX) has decided to sell Obagi Medical for $190 million and use the proceeds for reducing down debt.
Agenus Inc. (AGEN) moved big last session, as its shares rose over 8% on the day.